04/03/2024
4:30 PM | Bashan Dror (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
6:03 AM | Protalix BioTherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
5:57 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
5:36 AM | NACHT MARIUS (Filed by)
Protalix BioTherapeutics (Subject)
| Form SC 13G/A | |
12/26/2023
5:56 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
6:50 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
6:22 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/20/2023
5:50 AM | Bashan Dror (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
3:45 PM | Forster Eliot (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/15/2023
3:46 PM | Forster Eliot (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
5:58 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
3:30 PM | Naos Yaron (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:30 PM | Hayon Yael (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:30 PM | Protalix BioTherapeutics (Issuer)
Rubin Eyal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:30 PM | Bashan Dror (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
6:02 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023
5:59 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
3:41 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
6:24 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
3:30 PM | Protalix BioTherapeutics (Filer)
| Form DEFA14A | |
05/30/2023
6:23 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2023
5:57 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
5:25 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2023
5:56 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
3:30 PM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:37 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2023
7:26 AM | Protalix BioTherapeutics (Filer)
| Form PRE 14A | |
05/01/2023
5:47 AM | Protalix BioTherapeutics (Filer)
| Form 10-K/A | |
